Susan S.

Susan S. is a seasoned financial professional with extensive experience in financial planning and analysis across the biotechnology and pharmaceutical sectors. Currently serving as the Director of Financial Planning and Analysis at both Wave Life Sciences and Organogenesis, Susan has previously held significant roles at Ipsen, ImmunoGen, HeartWare Inc., EMD Serono, and Genzyme, demonstrating expertise in financial management, business operations, and strategic collaboration with cross-functional teams. With a strong educational background including a Master of Science in Regulatory Affairs, an MBA in Business Administration, and a BSBA in Business Administration from Northeastern University, Susan has consistently driven innovation, streamlined financial processes, and delivered actionable insights to enhance organizational performance.